| Similar Articles |
|---|
 |
Bio-IT World
April 2006
Kevin Davies |
Microsoft Forges BioIT Alliance The software giant's fledgling alliance aims to bring together companies from a cross-section of the industry -- from biotech and Big Pharma to equipment manufacturers and software developers -- to collaborate on technology that will speed drug discovery.   |
Bio-IT World
August 13, 2002
Russell & Dodge |
Necessary Liaisons: Making Standards Work Caroline Kovac, IBM Corp.'s general manager for life sciences, talks about the need for standards and her take on the troubled informatics world. |
Bio-IT World
May 2006
Kevin Davies |
Microsoft's 2020 Vision for Science The Microsoft Research report Towards 2020 is considered the first report to articulate a comprehensive vision of science towards 2020, particularly the impact of the convergence of computer science and the other sciences. |
Bio-IT World
November 14, 2003
John Russell |
China's Early Bet on Bio-IT A visit to Shanghai, China's future capital of biotech |
Bio-IT World
March 17, 2004 |
Signs of Spring Colin Hill, CEO of Gene Network Sciences, a predictive systems biology company, says the worst is behind the bio-IT industry. "The hype has dissipated, and companies are focused on delivering the results," he says. Hill's strategy includes developing additional products, which should generate near-term revenue. |
Bio-IT World
March 8, 2005
Michael A. Greeley |
What's New at Big Blue? The scale of computing has improved dramatically in the life sciences. But has the bio-IT industry over-promised, and does it risk under-delivering? Ultimately, customers will want to see a return on these investments, and that won't happen in two to three years. |
